These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 18045949)

  • 21. EVOLUTION OF TARGETED THERAPIES FOR THYROID CARCINOMA.
    Sherman SI
    Trans Am Clin Climatol Assoc; 2019; 130():255-265. PubMed ID: 31516190
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An update on molecular biology of thyroid cancers.
    Omur O; Baran Y
    Crit Rev Oncol Hematol; 2014 Jun; 90(3):233-52. PubMed ID: 24405857
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New Insights in Thyroid Cancer and p53 Family Proteins.
    Manzella L; Stella S; Pennisi MS; Tirrò E; Massimino M; Romano C; Puma A; Tavarelli M; Vigneri P
    Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28635633
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Classification of follicular cell-derived thyroid cancer by global RNA profiling.
    Rossing M
    J Mol Endocrinol; 2013 Apr; 50(2):R39-51. PubMed ID: 23355745
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The biology of thyroid oncogenesis.
    Suh I; Kebebew E
    Cancer Treat Res; 2010; 153():3-21. PubMed ID: 19957216
    [No Abstract]   [Full Text] [Related]  

  • 26. Molecular and genetic markers of follicular-cell thyroid cancer: etiology and diagnostic and therapeutic opportunities.
    Goyal N; Setabutr D; Abdulghani J; Goldenberg D
    Adv Exp Med Biol; 2013; 779():309-26. PubMed ID: 23288646
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Follicular cell-derived thyroid cancer in children.
    Leboulleux S; Baudin E; Hartl DW; Travagli JP; Schlumberger M
    Horm Res; 2005; 63(3):145-51. PubMed ID: 15802922
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pathogenesis of cancers derived from thyroid follicular cells.
    Fagin JA; Krishnamoorthy GP; Landa I
    Nat Rev Cancer; 2023 Sep; 23(9):631-650. PubMed ID: 37438605
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Update on thyroid cancer.
    Benvenga S
    Horm Metab Res; 2008 May; 40(5):323-8. PubMed ID: 18491251
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular diagnosis and targeted treatment of advanced follicular cell-derived thyroid cancer in the precision medicine era.
    Capdevila J; Awada A; Führer-Sakel D; Leboulleux S; Pauwels P
    Cancer Treat Rev; 2022 May; 106():102380. PubMed ID: 35305441
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MECHANISMS IN ENDOCRINOLOGY: MicroRNA in diagnostics and therapy of thyroid cancer.
    Wójcicka A; Kolanowska M; Jażdżewski K
    Eur J Endocrinol; 2016 Mar; 174(3):R89-98. PubMed ID: 26503845
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mutations of TSHR and TP53 Genes in an Aggressive Clear Cell Follicular Carcinoma of the Thyroid.
    Tong GX; Mody K; Wang Z; Hamele-Bena D; Nikiforova MN; Nikiforov YE
    Endocr Pathol; 2015 Dec; 26(4):315-9. PubMed ID: 26260781
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gene-expression profiling in differentiated thyroid cancer--a viable strategy for the practice of genomic medicine?
    Weber F; Eng C
    Future Oncol; 2005 Aug; 1(4):497-510. PubMed ID: 16556026
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeted therapy in refractory thyroid cancer.
    Schlumberger M;
    Eur J Cancer; 2011 Sep; 47 Suppl 3():S328-9. PubMed ID: 21944002
    [No Abstract]   [Full Text] [Related]  

  • 35. Origin and progression of thyroid epithelial tumours: cellular and molecular mechanisms.
    Wynford-Thomas D
    Horm Res; 1997; 47(4-6):145-57. PubMed ID: 9167946
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular biology of thyroid cancer initiation.
    Riesco-Eizaguirre G; Santisteban P
    Clin Transl Oncol; 2007 Nov; 9(11):686-93. PubMed ID: 18055323
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanisms and pathogenesis of thyroid cancer in animals and man.
    Williams ED
    Mutat Res; 1995 Dec; 333(1-2):123-9. PubMed ID: 8538619
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [What's new in follicular thyroid cancer management in 2014?].
    Abeillon-du Payrat J; Caron P; Borson-Chazot F
    Ann Endocrinol (Paris); 2014 Oct; 75 Suppl 1():S2-12. PubMed ID: 25617919
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Research advances in molecular pathogenesis of thyroid cancer].
    Aleha M; Meng QB; Yu JC; Kang WM; Cao ZJ; Tian SB
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2013 Aug; 35(4):382-5. PubMed ID: 23987483
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Revisiting immune-based therapies for aggressive follicular cell-derived thyroid cancers.
    French JD
    Thyroid; 2013 May; 23(5):529-42. PubMed ID: 23317509
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.